Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hormonal screening in impotent patients.

Y C Ou1, T I Hwang, C R Yang

  • 1Department of Surgery, Taichung Veterans General Hospital, Taiwan R.O.C.

Journal of the Formosan Medical Association = Taiwan Yi Zhi
|June 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression.

Immunity·1996
Same author

Determination of the appropriate fraction number and size of the HDR brachytherapy for cervical cancer.

Gynecologic oncology·1996
Same author

Galanin inhibits cholecystokinin secretion in STC-1 cells.

Biochemical and biophysical research communications·1995
Same author

Angiotensin IV receptors and signaling in opossum kidney cells.

The American journal of physiology·1995
Same author

Complete intrauterine resolution of fetal congenital cystic adenomatoid malformation of the lung type III.

Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine·1995
Same author

CIITA activates the expression of MHC class II genes in mouse T cells.

International immunology·1995
Same journal

Real-world analysis of autologous stem cell transplantation in primary central nervous system lymphoma using Taiwan Blood and Marrow Transplantation Registry.

Journal of the Formosan Medical Association = Taiwan yi zhi·2026
Same journal

Prognostic performance of the sarculator model in an Asian cohort of patients with extremity soft tissue sarcomas.

Journal of the Formosan Medical Association = Taiwan yi zhi·2026
Same journal

Amplification refractory mutation system polymerase chain reaction-capillary electrophoresis's applicability for newborn screening in dried blood spots of spinal muscular atrophy.

Journal of the Formosan Medical Association = Taiwan yi zhi·2026
Same journal

Comment on "Utilization of home-based traditional Chinese medicine in a homebound population under the integrated home-based medical care program in Taiwan".

Journal of the Formosan Medical Association = Taiwan yi zhi·2026
Same journal

Further considerations on early energy delivery and metabolic patterns in indirect calorimetry-guided nutrition for surgical ICU patients.

Journal of the Formosan Medical Association = Taiwan yi zhi·2026
Same journal

Response to "Comment on 'recent trends of LDL-C control and lipid-lowering therapy in patients with ASCVD in Taiwan: 2015-2020".

Journal of the Formosan Medical Association = Taiwan yi zhi·2026
See all related articles

Hormonal abnormalities, including hypotestosteronemia and hyperprolactinemia, affect 11.5% of impotent men. Testosterone therapy and bromocriptine show significant improvement rates, especially in cases without other organic causes.

Area of Science:

  • Endocrinology
  • Urology
  • Men's Health

Background:

  • Hormonal imbalances are a contributing factor in male impotence.
  • Identifying specific hormonal abnormalities is crucial for effective treatment.

Purpose of the Study:

  • To investigate the prevalence of serum testosterone and prolactin abnormalities in impotent patients.
  • To evaluate the efficacy of hormonal replacement therapy and medical treatment for these conditions.

Main Methods:

  • Serum testosterone and prolactin levels were measured in 260 impotent patients.
  • Patients with hormonal abnormalities received testosterone propionate injections or bromocriptine.
  • Treatment outcomes were assessed based on improvement in erectile function.

Related Experiment Videos

Main Results:

  • 11.5% of patients had hormonal abnormalities: 18 with hypotestosteronemia and 12 with hyperprolactinemia.
  • Testosterone therapy showed a 89% positive response rate for sole hypotestosteronemia and 44% when combined with other causes.
  • Bromocriptine treatment yielded a 71.4% positive response for sole hyperprolactinemia and 40% when combined with other causes.

Conclusions:

  • Hormonal abnormalities are significant contributors to male impotence.
  • Testosterone replacement and bromocriptine are effective treatments, with better outcomes when hormonal issues are the sole cause.
  • Combined hormonal and organic etiologies reduce treatment efficacy.